Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Tavalisse discount?

See the DrugPatentWatch profile for Tavalisse

What does “Tavalisse discount” usually refer to?

Most people mean one of these when they search “Tavalisse discount”:
- A manufacturer copay card or other patient savings program.
- Help lowering out-of-pocket costs for eligible patients (often tied to commercial insurance).
- Pharmacy coupons, third-party discount cards, or negotiated pricing.
- Patient assistance programs for uninsured or low-income patients.

Tavalisse is a brand name for fostamatinib, used for thrombocytopenia in certain immune-related conditions.

Where can you actually get a discount for Tavalisse?

The most common route is through the drug’s official patient support offerings (copay cards or savings programs), because they’re designed to apply at the pharmacy. Patients can also check with:
- Their pharmacy (they can run pricing through common discount networks).
- Their insurer’s formulary and prior authorization rules (coverage level can change your price a lot).
- The manufacturer’s patient assistance program if you may qualify based on income and insurance status.

If you tell me your insurance type (commercial, Medicare, Medicaid, or uninsured) and what country you’re in, I can point you to the most likely option.

Why Tavalisse prices can vary so much

Even with a discount program, the final price usually depends on:
- Insurance coverage and plan tier (preferred vs non-preferred).
- Whether the pharmacy can process the savings program as intended for your coverage.
- Your deductible status.
- Whether you’re buying through a specialty pharmacy.
- Eligibility rules (for example, copay support often doesn’t apply to certain government insurance plans).

Are there alternative ways to lower the cost?

Depending on coverage and eligibility, people sometimes lower costs by:
- Switching to an in-formulary option if your insurer offers one.
- Using prior authorization approval pathways (required for many specialty meds).
- Trying manufacturer patient assistance if copay cards don’t apply to your coverage.

If a generic is available in your region, that can also change pricing, but availability depends on the market.

Quick questions so I can narrow it down

1) What country are you in?
2) Do you have commercial insurance, Medicare, Medicaid, or are you uninsured?
3) Are you looking for a copay card/savings program, or a coupon/discount at the pharmacy?



Other Questions About Tavalisse :

tavalisse patent litigation rigel pharmaceuticals march 2025 tavalisse manufacturer tavalisse cost of tavalisse How does Tavalisse treat low platelet counts? Rigel pharmaceuticals tavalisse patent settlement 2025?

AI-Drug Label Prescribing Information Alignment Report

88
88%
Grade B

Good

Mostly Aligned

Patient Risk: Low

Summary

The evaluated claims correctly identify Tavalisse as fostamatinib and state the approved indication for adult chronic immune thrombocytopenia with insufficient response to prior treatment. No dosage, safety, contraindications, warnings, or other label elements were claimed, so the main gap is omission of label specifics (e.g., “adult,” chronic ITP wording).


Category Scores

Indication
92
Excellent
SpecificPopulations
85
Good

Accurate Statements

Tavalisse is a brand name for fostamatinib.
Label (identified drug/active ingredient): TAVALISSE (fostamatinib).
Fostamatinib (Tavalisse) is used for thrombocytopenia in certain immune-related conditions.
Label Section 1: indicated for treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.

Unsupported Statements


Contradictions


Important Omissions

The indication is specifically for adult patients with chronic immune thrombocytopenia (ITP) with an insufficient response to a previous treatment; the claim is phrased more generally (“certain immune-related conditions”) and does not include adult/chronic/insufficient-response qualifiers.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The statements are limited to identity and a high-level description of the approved indication, without dosing or safety claims. Minor omission of key qualifying details (adult/chronic/insufficient response) could affect accuracy but is not inherently a safety-promoting risk in the provided text.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
Indication wording is too general and omits key label qualifiers (adult, chronic ITP, insufficient response to prior treatment).

Suggested Improvement
Rephrase to match Section 1: “TAVALISSE is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.”

Drug Brand Mention Assessment

Branding Score
34
Visibility
45
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

a brand name for fostamatinib


Core Claims
  • Tavalisse is a brand name for fostamatinib
  • Tavalisse is used for thrombocytopenia in certain immune-related conditions
  • Discounts are often through copay cards or other patient savings programs
  • The most common route is through the drug’s official patient support offerings
  • Eligibility rules can affect whether copay support applies
Differentiators

Pricing Perception: Not Mentioned